CN110693031A - 一种用于苯丙酮尿症患者的配方粉及其制备方法 - Google Patents
一种用于苯丙酮尿症患者的配方粉及其制备方法 Download PDFInfo
- Publication number
- CN110693031A CN110693031A CN201810750645.5A CN201810750645A CN110693031A CN 110693031 A CN110693031 A CN 110693031A CN 201810750645 A CN201810750645 A CN 201810750645A CN 110693031 A CN110693031 A CN 110693031A
- Authority
- CN
- China
- Prior art keywords
- acid
- vitamin
- formula powder
- mass
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 74
- 201000011252 Phenylketonuria Diseases 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- -1 compound amino acid Chemical class 0.000 claims abstract description 36
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 25
- 239000011707 mineral Substances 0.000 claims abstract description 25
- 229940088594 vitamin Drugs 0.000 claims abstract description 25
- 229930003231 vitamin Natural products 0.000 claims abstract description 25
- 235000013343 vitamin Nutrition 0.000 claims abstract description 25
- 239000011782 vitamin Substances 0.000 claims abstract description 25
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims abstract description 20
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims abstract description 18
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 17
- 239000008158 vegetable oil Substances 0.000 claims abstract description 17
- 239000002773 nucleotide Substances 0.000 claims abstract description 15
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 15
- 150000001413 amino acids Chemical class 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 10
- 230000008569 process Effects 0.000 claims abstract description 9
- 239000000126 substance Substances 0.000 claims abstract description 9
- 150000001875 compounds Chemical class 0.000 claims abstract description 8
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 6
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 6
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 6
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims description 56
- 229930003270 Vitamin B Natural products 0.000 claims description 28
- 235000019156 vitamin B Nutrition 0.000 claims description 28
- 239000011720 vitamin B Substances 0.000 claims description 28
- 229940024606 amino acid Drugs 0.000 claims description 27
- 235000001014 amino acid Nutrition 0.000 claims description 27
- 238000002156 mixing Methods 0.000 claims description 23
- 238000003756 stirring Methods 0.000 claims description 22
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 21
- 238000007689 inspection Methods 0.000 claims description 21
- 238000004806 packaging method and process Methods 0.000 claims description 21
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 16
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 16
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 16
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 16
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 16
- 239000000047 product Substances 0.000 claims description 15
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 14
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 14
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 14
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 14
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 14
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 14
- 238000005070 sampling Methods 0.000 claims description 14
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 14
- 239000002131 composite material Substances 0.000 claims description 11
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 11
- 229960004441 tyrosine Drugs 0.000 claims description 10
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 9
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 9
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 9
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 9
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 9
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 9
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims description 9
- 239000004158 L-cystine Substances 0.000 claims description 9
- 235000019393 L-cystine Nutrition 0.000 claims description 9
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 9
- 229930182816 L-glutamine Natural products 0.000 claims description 9
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 9
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 claims description 9
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 9
- 229960005261 aspartic acid Drugs 0.000 claims description 9
- 229960003067 cystine Drugs 0.000 claims description 9
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 8
- AUHDWARTFSKSAC-HEIFUQTGSA-N (2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-(6-oxo-1H-purin-9-yl)oxolane-2-carboxylic acid Chemical compound [C@]1([C@H](O)[C@H](O)[C@@H](CO)O1)(N1C=NC=2C(O)=NC=NC12)C(=O)O AUHDWARTFSKSAC-HEIFUQTGSA-N 0.000 claims description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 7
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 7
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 7
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 7
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 claims description 7
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 7
- 229930183912 Cytidylic acid Natural products 0.000 claims description 7
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 239000004471 Glycine Substances 0.000 claims description 7
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 7
- GRSZFWQUAKGDAV-UHFFFAOYSA-N Inosinic acid Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-UHFFFAOYSA-N 0.000 claims description 7
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 7
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims description 7
- 229930064664 L-arginine Natural products 0.000 claims description 7
- 235000014852 L-arginine Nutrition 0.000 claims description 7
- 229930182844 L-isoleucine Natural products 0.000 claims description 7
- 239000004395 L-leucine Substances 0.000 claims description 7
- 235000019454 L-leucine Nutrition 0.000 claims description 7
- 229930195722 L-methionine Natural products 0.000 claims description 7
- 229930182821 L-proline Natural products 0.000 claims description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 7
- 229920000881 Modified starch Polymers 0.000 claims description 7
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 7
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 7
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 7
- 239000004473 Threonine Substances 0.000 claims description 7
- DJJCXFVJDGTHFX-UHFFFAOYSA-N Uridinemonophosphate Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-UHFFFAOYSA-N 0.000 claims description 7
- FOGRQMPFHUHIGU-UHFFFAOYSA-N Uridylic acid Natural products OC1C(OP(O)(O)=O)C(CO)OC1N1C(=O)NC(=O)C=C1 FOGRQMPFHUHIGU-UHFFFAOYSA-N 0.000 claims description 7
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 7
- 229930003268 Vitamin C Natural products 0.000 claims description 7
- 229930003316 Vitamin D Natural products 0.000 claims description 7
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 7
- 229930003427 Vitamin E Natural products 0.000 claims description 7
- 229930003448 Vitamin K Natural products 0.000 claims description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 7
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims description 7
- 229950006790 adenosine phosphate Drugs 0.000 claims description 7
- 229960003767 alanine Drugs 0.000 claims description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 7
- 229960002685 biotin Drugs 0.000 claims description 7
- 235000020958 biotin Nutrition 0.000 claims description 7
- 239000011616 biotin Substances 0.000 claims description 7
- 239000011575 calcium Substances 0.000 claims description 7
- 229910052791 calcium Inorganic materials 0.000 claims description 7
- 239000000460 chlorine Substances 0.000 claims description 7
- 229910052801 chlorine Inorganic materials 0.000 claims description 7
- 229960001231 choline Drugs 0.000 claims description 7
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 7
- 229910052802 copper Inorganic materials 0.000 claims description 7
- 239000010949 copper Substances 0.000 claims description 7
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 claims description 7
- IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 7
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 7
- 239000003995 emulsifying agent Substances 0.000 claims description 7
- 229930195729 fatty acid Natural products 0.000 claims description 7
- 239000000194 fatty acid Substances 0.000 claims description 7
- 150000004665 fatty acids Chemical class 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 7
- 229960000304 folic acid Drugs 0.000 claims description 7
- 235000019152 folic acid Nutrition 0.000 claims description 7
- 239000011724 folic acid Substances 0.000 claims description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 claims description 7
- 239000004226 guanylic acid Substances 0.000 claims description 7
- 235000013928 guanylic acid Nutrition 0.000 claims description 7
- 229960002885 histidine Drugs 0.000 claims description 7
- 239000004245 inosinic acid Substances 0.000 claims description 7
- 235000013902 inosinic acid Nutrition 0.000 claims description 7
- 229940028843 inosinic acid Drugs 0.000 claims description 7
- 229960000367 inositol Drugs 0.000 claims description 7
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 7
- 239000011630 iodine Substances 0.000 claims description 7
- 229910052740 iodine Inorganic materials 0.000 claims description 7
- 229910052742 iron Inorganic materials 0.000 claims description 7
- 229960000310 isoleucine Drugs 0.000 claims description 7
- 229960003136 leucine Drugs 0.000 claims description 7
- 239000011777 magnesium Substances 0.000 claims description 7
- 229910052749 magnesium Inorganic materials 0.000 claims description 7
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 7
- 229960004452 methionine Drugs 0.000 claims description 7
- 229960003512 nicotinic acid Drugs 0.000 claims description 7
- 235000001968 nicotinic acid Nutrition 0.000 claims description 7
- 239000011664 nicotinic acid Substances 0.000 claims description 7
- 229940055726 pantothenic acid Drugs 0.000 claims description 7
- 235000019161 pantothenic acid Nutrition 0.000 claims description 7
- 239000011713 pantothenic acid Substances 0.000 claims description 7
- 239000011574 phosphorus Substances 0.000 claims description 7
- 229910052698 phosphorus Inorganic materials 0.000 claims description 7
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 7
- 239000011591 potassium Substances 0.000 claims description 7
- 229910052700 potassium Inorganic materials 0.000 claims description 7
- 229960002429 proline Drugs 0.000 claims description 7
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 7
- 239000011669 selenium Substances 0.000 claims description 7
- 229910052711 selenium Inorganic materials 0.000 claims description 7
- 229960001153 serine Drugs 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- 229910052708 sodium Inorganic materials 0.000 claims description 7
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 238000001694 spray drying Methods 0.000 claims description 7
- 239000006188 syrup Substances 0.000 claims description 7
- 235000020357 syrup Nutrition 0.000 claims description 7
- 229960003080 taurine Drugs 0.000 claims description 7
- 229960002898 threonine Drugs 0.000 claims description 7
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 claims description 7
- 229960004295 valine Drugs 0.000 claims description 7
- 235000019155 vitamin A Nutrition 0.000 claims description 7
- 239000011719 vitamin A Substances 0.000 claims description 7
- 235000019154 vitamin C Nutrition 0.000 claims description 7
- 239000011718 vitamin C Substances 0.000 claims description 7
- 235000019166 vitamin D Nutrition 0.000 claims description 7
- 239000011710 vitamin D Substances 0.000 claims description 7
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 7
- 235000019165 vitamin E Nutrition 0.000 claims description 7
- 229940046009 vitamin E Drugs 0.000 claims description 7
- 239000011709 vitamin E Substances 0.000 claims description 7
- 235000019168 vitamin K Nutrition 0.000 claims description 7
- 239000011712 vitamin K Substances 0.000 claims description 7
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 7
- 229940045997 vitamin a Drugs 0.000 claims description 7
- 229940046008 vitamin d Drugs 0.000 claims description 7
- 229940046010 vitamin k Drugs 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 239000011701 zinc Substances 0.000 claims description 7
- 229910052725 zinc Inorganic materials 0.000 claims description 7
- 240000000560 Citrus x paradisi Species 0.000 claims description 5
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 5
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 5
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 5
- 244000299461 Theobroma cacao Species 0.000 claims description 5
- 235000019219 chocolate Nutrition 0.000 claims description 5
- 239000008369 fruit flavor Substances 0.000 claims description 5
- QZNNVYOVQUKYSC-JEDNCBNOSA-N (2s)-2-amino-3-(1h-imidazol-5-yl)propanoic acid;hydron;chloride Chemical compound Cl.OC(=O)[C@@H](N)CC1=CN=CN1 QZNNVYOVQUKYSC-JEDNCBNOSA-N 0.000 claims description 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 4
- KWTQSFXGGICVPE-UHFFFAOYSA-N 2-amino-5-(diaminomethylideneamino)pentanoic acid;hydron;chloride Chemical compound Cl.OC(=O)C(N)CCCN=C(N)N KWTQSFXGGICVPE-UHFFFAOYSA-N 0.000 claims description 2
- 239000004201 L-cysteine Substances 0.000 claims description 2
- 235000013878 L-cysteine Nutrition 0.000 claims description 2
- IFQSXNOEEPCSLW-DKWTVANSSA-N L-cysteine hydrochloride Chemical compound Cl.SC[C@H](N)C(O)=O IFQSXNOEEPCSLW-DKWTVANSSA-N 0.000 claims description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 2
- RRNJROHIFSLGRA-JEDNCBNOSA-N acetic acid;(2s)-2,6-diaminohexanoic acid Chemical compound CC(O)=O.NCCCC[C@H](N)C(O)=O RRNJROHIFSLGRA-JEDNCBNOSA-N 0.000 claims description 2
- 229960002433 cysteine Drugs 0.000 claims description 2
- 229960002989 glutamic acid Drugs 0.000 claims description 2
- RXMQCXCANMAVIO-CEOVSRFSSA-L magnesium;(2s)-2-amino-4-hydroxy-4-oxobutanoate Chemical compound [H+].[H+].[Mg+2].[O-]C(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC([O-])=O RXMQCXCANMAVIO-CEOVSRFSSA-L 0.000 claims description 2
- 240000009088 Fragaria x ananassa Species 0.000 claims 1
- 240000008790 Musa x paradisiaca Species 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 abstract description 5
- 238000009825 accumulation Methods 0.000 abstract description 4
- 150000004715 keto acids Chemical class 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 235000013350 formula milk Nutrition 0.000 abstract 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 36
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 20
- 229940114079 arachidonic acid Drugs 0.000 description 18
- 235000021342 arachidonic acid Nutrition 0.000 description 18
- 235000019197 fats Nutrition 0.000 description 16
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 14
- 229940090949 docosahexaenoic acid Drugs 0.000 description 10
- 230000018109 developmental process Effects 0.000 description 5
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 4
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 4
- 241000220223 Fragaria Species 0.000 description 4
- 241000234295 Musa Species 0.000 description 4
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 1
- 208000029751 Amino acid metabolism disease Diseases 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 208000021024 autosomal recessive inheritance Diseases 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000035614 depigmentation Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明的目的在于公开了一种用于苯丙酮尿症患者的配方粉及其制备方法,它由如下质量百分比的组份制备而成:植物油脂肪粉60‑90%,复合氨基酸8‑20%,低聚果糖(Fos)0‑6.45%,低聚半乳糖(Gos)0‑6.45%,核苷酸0.012‑0.058%,复合维生素0.044‑0.13%和复合矿物质1.195‑4.717%,所述配方粉中不包含苯丙氨酸;与现有技术相比,以脂肪、碳水化合物、氨基酸、维生素、矿物质等为基本的组成,配比科学,能满足婴幼儿的生长发育的需要;其中植物油脂肪粉中含有脂肪和碳水化合物,为机体提供能量,复合氨基酸为人体补充生长发育过程中必需的氨基酸,并且不添加苯丙氨酸,既不产生苯丙氨酸及其酮酸的蓄积,又保证患者的氨基酸摄入,维持机体的氨基酸正常代谢,实现本发明的目的。
Description
技术领域
本发明涉及一种配方粉及其制备方法,特别涉及一种用于苯丙酮尿症患者的配方粉及其制备方法。
背景技术
苯丙酮尿症(phenylketonuria,PKU)是一种常见的氨基酸代谢障碍疾病,是由于苯丙氨酸(PA)代谢途径中的酶缺陷,使得苯丙氨酸不能转变成为酪氨酸,导致苯丙氨酸及其酮酸蓄积,并从尿中大量排出。
苯丙酮尿症在遗传性氨基酸代谢缺陷疾病中比较常见,发病率为1/10000。其遗传方式为常染色体隐性遗传。临床表现不均一,主要临床特征为智力低下、精神神经症状、湿疹、皮肤抓痕征及色素脱失和鼠气味等、脑电图异常。
苯丙酮尿症如果能得到早期诊断和早期治疗,则前述临床表现可不发生,智力正常,脑电图异常也可得到恢复。
但是,由于一般的食物、奶粉和母乳中都包含有苯丙氨酸,为了应对苯丙酮尿症,需要对患者进行饮食控制,限制苯丙氨酸的摄入。
因此,特别需要一种用于苯丙酮尿症患者的配方粉及其制备方法,以解决上述现有存在的问题。
发明内容
本发明的目的在于提供一种用于苯丙酮尿症患者的配方粉及其制备方法,针对现有技术的不足,既不产生苯丙氨酸及其酮酸的蓄积,又保证患者的氨基酸摄入,维持机体的氨基酸正常代谢。
为了实现上述目的,本发明所解决的技术问题可以采用以下技术方案来实现:
第一方面,本发明提供一种用于苯丙酮尿症患者的配方粉,其特征在于,它由如下质量百分比的组份制备而成:
植物油脂肪粉60-90%,复合氨基酸8-20%,低聚果糖(Fos)0-6.45%,低聚半乳糖(Gos)0-6.45%,核苷酸0.012-0.058%,复合维生素0.06-0.41%和复合矿物质1.059-4.717%,所述配方粉中不包含苯丙氨酸。
在本发明的一个实施例中,所述复合氨基酸由以下氨基酸组成:L-丙氨酸;L-精氨酸和/或L-盐酸精氨酸、L-天冬氨酸和/或L-天冬氨酸镁;L-胱氨酸、L-半胱氨酸、L-盐酸半胱氨酸中的一种或多种组合;L-谷氨酸、L-谷氨酸钾、L-谷氨酰胺中的一种或多种组合;甘氨酸;L-组氨酸和/或L-盐酸组氨酸;L-异亮氨酸、L-亮氨酸;L-盐酸赖氨酸和/或L-赖氨酸醋酸盐;L-甲硫氨酸和/或L-乙酰-甲硫氨酸;L-脯氨酸;L-丝氨酸;L-苏氨酸;L-色氨酸;L-酪氨酸;L-缬氨酸,并且L-酪氨酸占所述复合氨基酸重量的7-11%。
在本发明的一个实施例中,所述复合氨基酸由以下质量百分比的组分组成: L-丙氨酸0.2-0.4%、L-精氨酸0.2-0.5%、L-天冬氨酸0.7-1.0%、L-胱氨酸0.15-0.35%、L-谷氨酰胺1.6-2.0%、甘氨酸0.1-0.3%、L-组氨酸0.3-0.5%、L-异亮氨酸0.8-1.1%、L-亮氨酸1.4-1.6%、L-盐酸赖氨酸0.8-1.2%、L-甲硫氨酸0.2-0.4%、L-脯氨酸0.8-1.1%、L-丝氨酸0.3-0.6%、L-苏氨酸0.5-0.7%、L-色氨酸0.2-0.4%、L-酪氨酸0.8-1.2%和L-缬氨酸0.8-1.2%。
在本发明的一个实施例中,所述植物油脂肪粉由固体葡萄糖浆、预糊化淀粉、脂肪酸、乳化剂通过喷雾干燥而制成。植物脂肪粉中包含脂肪和碳水化合物,为机体提供能量。
在本发明的一个实施例中,所述核苷酸由腺苷酸、尿苷酸、鸟苷酸、胞苷酸、肌苷酸组成,其质量比为2.9:3.5:1.0:5.1:2.0。
在本发明的一个实施例中,所述复合维生素由以下质量百分比的组分组成:维生素A0.00029-0.0009%、维生素C0.0525-0.357%、维生素D0.00000525-0.0000126%、维生素E0.00252-0.0252%、维生素K10.000021-0.0001365%、维生素B10.000294-0.001512%、维生素B20.000399-0.002499%、维生素B60.0001785-0.000945%、维生素B120.000000525-0.00000756%、烟酸0.00147-0.00756%、叶酸0.0000525-0.000252%、泛酸0.002-0.01%、生物素0.0000084-0.0000504%、肌醇0.021-0.1995%、胆碱0.0357-0.252%和牛磺酸0-0.063%。复合维生素为患者提供身体所需的维生素,参与身体的各种生化反应。
在本发明的一个实施例中,所述复合矿物质由以下质量百分比的组分组成:钠0.105-0.294%、氯0.252-0.798%、钾0.294-0.903%、钙0.252-0.735%、磷0.126-0.504%、铁0.0021-0.00756%、锌0.00252-0.00756%、锰0.0000252-0.000504%、铜0.0001785-0.000609%、镁0.0252-0.0756%、硒0.00001-0.0000399%和碘0.0000525-0.000294%。矿物质是构成机体组织的重要成份;维持机体的酸碱平衡及组织细胞渗透压;维持神经肌肉兴奋性和细胞膜的通透性。
在本发明的一个实施例中,所述配方粉还包含质量百分比的复合不饱和脂肪酸0.12-0.16%,所述复合不饱和脂肪酸由DHA和ARA组成,DHA与ARA的重量比为1:1.8。含有复合不饱和脂肪酸的配方粉可用于0-10岁的患儿,长链不饱和脂肪酸,促进大脑的发育,提高认知能力;促进身体发育,保证健康体质;保证视力发育,降低视力缺陷;呵护早产婴儿,提高健康程度;支持免疫发育,提高呼吸系统健康。10岁以上的患者的配方粉可不需要包含所述复合不饱和脂肪酸。
在本发明的一个实施例中,所述配方粉还包含质量百分比的香精0.0-0.5%。所述香精为巧克力、香蕉、草莓、橙子、西柚及其他水果味中的一种。香精的添加可为本发明的配方粉提供特有的风味,以适合不同的患者。
第二方面,本发明提供一种用于苯丙酮尿症患者的配方粉的制备方法,其特征在于,它包括以下步骤:
(1)配料:将按预定比例称取原辅料,经复核准确后备用;
(2)投料:将已称量好的原辅料经投料站输送至混合机中;投料时注意将维生素、矿物质等质量比较小的原料放在大宗原料的中间投送,防止小料粘附在设备表面影响均匀性;
(3)混合搅拌:待所有的原辅料投送完毕,开启混合机搅拌,搅拌时间一般为8-12分钟(按混合的均匀程度确定混合时间);
(4)接料暂存:将混合好的物料输送至粉仓中暂存,检验部门取样进行过程产品检验;
(5)包装:采用自动包装机进行产品包装;
(6)检验:检验部门取样进行终产品检测。
在本发明的一个实施例中,所述的配方粉的制备方法,其特征在于,所述混合搅拌步骤,推荐使用三维混合机,确定适宜的混合时间,以确保产品各项指标的均匀性。
本发明的用于苯丙酮尿症患者的配方粉及其制备方法,与现有技术相比,以脂肪、碳水化合物、氨基酸、维生素、矿物质等为基本的组成,配比科学,能满足婴幼儿的生长发育的需要;其中植物油脂肪粉中含有脂肪和碳水化合物,为机体提供能量,复合氨基酸为人体补充生长发育过程中必需的氨基酸,并且不添加苯丙氨酸,既不产生苯丙氨酸及其酮酸的蓄积,又保证患者的氨基酸摄入,维持机体的氨基酸正常代谢,实现本发明的目的。
本发明的特点可参阅本案以下较好实施方式的详细说明而获得清楚地了解。
具体实施方式
为了使本发明实现的技术手段、创作特征、达成目的与功效易于明白了解,下面结合具体实施例进一步阐述本发明。
实施例1
本发明的用于苯丙酮尿症患者的配方粉由如下质量百分比的组份制备而成:植物油脂肪粉82.26%,复合氨基酸14%,核苷酸0.03%,二十二碳六烯酸(DHA)0.05%,二十碳四烯酸(ARA)0.09%,香精0.1%,复合维生素0.57%和复合矿物质2.9%,所述配方粉中不包含苯丙氨酸。
所述复合氨基酸由以下质量百分比的组分组成: L-丙氨酸0.2-0.4%、L-精氨酸0.2-0.5%、L-天冬氨酸0.7-1.0%、L-胱氨酸0.15-0.35%、L-谷氨酰胺1.6-2.0%、甘氨酸0.1-0.3%、L-组氨酸0.3-0.5%、L-异亮氨酸0.8-1.1%、L-亮氨酸1.4-1.6%、L-盐酸赖氨酸0.8-1.2%、L-甲硫氨酸0.2-0.4%、L-脯氨酸0.8-1.1%、L-丝氨酸0.3-0.6%、L-苏氨酸0.5-0.7%、L-色氨酸0.2-0.4%、L-酪氨酸0.8-1.2%和L-缬氨酸0.8-1.2%。
所述植物油脂肪粉由固体葡萄糖浆、预糊化淀粉、脂肪酸、乳化剂通过喷雾干燥而制成。
所述核苷酸由腺苷酸、尿苷酸、鸟苷酸、胞苷酸、肌苷酸组成,其质量比为2.9:3.5:1.0:5.1:2.0。
所述复合维生素由以下质量百分比的组分组成:维生素A0.00029-0.0009%、维生素C0.0525-0.357%、维生素D0.00000525-0.0000126%、维生素E0.00252-0.0252%、维生素K10.000021-0.0001365%、维生素B10.000294-0.001512%、维生素B20.000399-0.002499%、维生素B60.0001785-0.000945%、维生素B120.000000525-0.00000756%、烟酸0.00147-0.00756%、叶酸0.0000525-0.000252%、泛酸0.002-0.01%、生物素0.0000084-0.0000504%、肌醇0.021-0.1995%、胆碱0.0357-0.252%和牛磺酸0-0.063%。
所述复合矿物质由以下质量百分比的组分组成:钠0.105-0.294%、氯0.252-0.798%、钾0.294-0.903%、钙0.252-0.735%、磷0.126-0.504%、铁0.0021-0.00756%、锌0.00252-0.00756%、锰0.0000252-0.000504%、铜0.0001785-0.000609%、镁0.0252-0.0756%、硒0.00001-0.0000399%和碘0.0000525-0.000294%。
所述香精为巧克力、香蕉、草莓、橙子、西柚及其他水果味中的一种。香精的添加可为本发明的配方粉提供特有的风味,以适合不同的患者。
所述复合不饱和脂肪酸由DHA和ARA组成,DHA与ARA的重量比为1:1.8。
上述用于苯丙酮尿症患者的配方粉的制备方法如下:
(1)配料:将按预定比例称取原辅料,经复核准确后备用;
(2)投料:将已称量好的原辅料经投料站输送至三维混合机中;投料时注意将维生素、矿物质等质量比较小的原料放在大宗原料的中间投送,防止小料粘附在设备表面影响均匀性;
(3)混合搅拌:待所有的原辅料投送完毕,开启混合机搅拌,搅拌时间一般为8-12分钟(按混合的均匀程度确定混合时间);
(4)接料暂存:将混合好的物料输送至粉仓中暂存,检验部门取样进行过程产品检验;
(5)包装:采用自动包装机进行产品包装;
(6)检验:检验部门取样进行终产品检测。
实施例2
本发明的用于苯丙酮尿症患者的配方粉由如下质量百分比的组份制备而成:
植物油脂肪粉79.883%,复合氨基酸14%,低聚果糖(Fos)0.1%,低聚半乳糖(Gos)0.9%,核苷酸0.05%,二十二碳六烯酸(DHA)0.0525%,二十碳四烯酸(ARA)0.0945%,香精0.3%,复合维生素0.12%和复合矿物质4.5%,所述配方粉中不包含苯丙氨酸。
所述复合氨基酸由以下质量百分比的组分组成: L-丙氨酸0.2-0.4%、L-精氨酸0.2-0.5%、L-天冬氨酸0.7-1.0%、L-胱氨酸0.15-0.35%、L-谷氨酰胺1.6-2.0%、甘氨酸0.1-0.3%、L-组氨酸0.3-0.5%、L-异亮氨酸0.8-1.1%、L-亮氨酸1.4-1.6%、L-盐酸赖氨酸0.8-1.2%、L-甲硫氨酸0.2-0.4%、L-脯氨酸0.8-1.1%、L-丝氨酸0.3-0.6%、L-苏氨酸0.5-0.7%、L-色氨酸0.2-0.4%、L-酪氨酸0.8-1.2%和L-缬氨酸0.8-1.2%。
所述植物油脂肪粉由固体葡萄糖浆、预糊化淀粉、脂肪酸、乳化剂通过喷雾干燥而制成。
所述核苷酸由腺苷酸、尿苷酸、鸟苷酸、胞苷酸、肌苷酸组成,其质量比为2.9:3.5:1.0:5.1:2.0。
所述复合维生素由以下质量百分比的组分组成:维生素A0.00029-0.0009%、维生素C0.0525-0.357%、维生素D0.00000525-0.0000126%、维生素E0.00252-0.0252%、维生素K10.000021-0.0001365%、维生素B10.000294-0.001512%、维生素B20.000399-0.002499%、维生素B60.0001785-0.000945%、维生素B120.000000525-0.00000756%、烟酸0.00147-0.00756%、叶酸0.0000525-0.000252%、泛酸0.002-0.01%、生物素0.0000084-0.0000504%、肌醇0.021-0.1995%、胆碱0.0357-0.252%和牛磺酸0-0.063%。
所述复合矿物质由以下质量百分比的组分组成:钠0.105-0.294%、氯0.252-0.798%、钾0.294-0.903%、钙0.252-0.735%、磷0.126-0.504%、铁0.0021-0.00756%、锌0.00252-0.00756%、锰0.0000252-0.000504%、铜0.0001785-0.000609%、镁0.0252-0.0756%、硒0.00001-0.0000399%和碘0.0000525-0.000294%。
所述香精为巧克力、香蕉、草莓、橙子、西柚及其他水果味中的一种。香精的添加可为本发明的配方粉提供特有的风味,以适合不同的患者。
所述复合不饱和脂肪酸由DHA和ARA组成,DHA与ARA的重量比为1:1.8。
上述用于苯丙酮尿症患者的配方粉的制备方法如下:
(1)配料:将按预定比例称取原辅料,经复核准确后备用;
(2)投料:将已称量好的原辅料经投料站输送至三维混合机中;投料时注意将维生素、矿物质等质量比较小的原料放在大宗原料的中间投送,防止小料粘附在设备表面影响均匀性;
(3)混合搅拌:待所有的原辅料投送完毕,开启混合机搅拌,搅拌时间一般为8-12分钟(按混合的均匀程度确定混合时间);
(4)接料暂存:将混合好的物料输送至粉仓中暂存,检验部门取样进行过程产品检验;
(5)包装:采用自动包装机进行产品包装;
(6)检验:检验部门取样进行终产品检测。
实施例3
本发明的用于苯丙酮尿症患者的配方粉由如下质量百分比的组份制备而成:
植物油脂肪粉88.296%,复合氨基酸8%,核苷酸0.035%,二十二碳六烯酸(DHA)0.045%,二十碳四烯酸(ARA)0.081%,香精0.5%,复合维生素0.087%和复合矿物质2.956%,所述配方粉中不包含苯丙氨酸。
所述复合氨基酸由以下质量百分比的组分组成: L-丙氨酸0.2-0.4%、L-精氨酸0.2-0.5%、L-天冬氨酸0.7-1.0%、L-胱氨酸0.15-0.35%、L-谷氨酰胺1.6-2.0%、甘氨酸0.1-0.3%、L-组氨酸0.3-0.5%、L-异亮氨酸0.8-1.1%、L-亮氨酸1.4-1.6%、L-盐酸赖氨酸0.8-1.2%、L-甲硫氨酸0.2-0.4%、L-脯氨酸0.8-1.1%、L-丝氨酸0.3-0.6%、L-苏氨酸0.5-0.7%、L-色氨酸0.2-0.4%、L-酪氨酸0.8-1.2%和L-缬氨酸0.8-1.2%。
所述植物油脂肪粉由固体葡萄糖浆、预糊化淀粉、脂肪酸、乳化剂通过喷雾干燥而制成。
所述核苷酸由腺苷酸、尿苷酸、鸟苷酸、胞苷酸、肌苷酸组成,其质量比为2.9:3.5:1.0:5.1:2.0。
所述复合维生素由以下质量百分比的组分组成:维生素A0.00029-0.0009%、维生素C0.0525-0.357%、维生素D0.00000525-0.0000126%、维生素E0.00252-0.0252%、维生素K10.000021-0.0001365%、维生素B10.000294-0.001512%、维生素B20.000399-0.002499%、维生素B60.0001785-0.000945%、维生素B120.000000525-0.00000756%、烟酸0.00147-0.00756%、叶酸0.0000525-0.000252%、泛酸0.002-0.01%、生物素0.0000084-0.0000504%、肌醇0.021-0.1995%、胆碱0.0357-0.252%和牛磺酸0-0.063%。
所述复合矿物质由以下质量百分比的组分组成:钠0.105-0.294%、氯0.252-0.798%、钾0.294-0.903%、钙0.252-0.735%、磷0.126-0.504%、铁0.0021-0.00756%、锌0.00252-0.00756%、锰0.0000252-0.000504%、铜0.0001785-0.000609%、镁0.0252-0.0756%、硒0.00001-0.0000399%和碘0.0000525-0.000294%。
所述香精为巧克力、香蕉、草莓、橙子、西柚及其他水果味中的一种。香精的添加可为本发明的配方粉提供特有的风味,以适合不同的患者。
所述复合不饱和脂肪酸由DHA和ARA组成,DHA与ARA的重量比为1:1.8。
上述用于苯丙酮尿症患者的配方粉的制备方法如下:
(1)配料:将按预定比例称取原辅料,经复核准确后备用;
(2)投料:将已称量好的原辅料经投料站输送至三维混合机中;投料时注意将维生素、矿物质等质量比较小的原料放在大宗原料的中间投送,防止小料粘附在设备表面影响均匀性;
(3)混合搅拌:待所有的原辅料投送完毕,开启混合机搅拌,搅拌时间一般为8-12分钟(按混合的均匀程度确定混合时间);
(4)接料暂存:将混合好的物料输送至粉仓中暂存,检验部门取样进行过程产品检验;
(5)包装:采用自动包装机进行产品包装;
(6)检验:检验部门取样进行终产品检测。
实施例4
本发明的用于苯丙酮尿症患者的配方粉由如下质量百分比的组份制备而成:
植物油脂肪粉81.55%,复合氨基酸8.589%,低聚果糖(Fos)6.45%,低聚半乳糖(Gos)1.006%,核苷酸0.012%,二十二碳六烯酸(DHA)0.055%,二十碳四烯酸(ARA)0.099%,复合维生素0.044%和复合矿物质2.195%,所述配方粉中不包含苯丙氨酸。
所述复合氨基酸由以下质量百分比的组分组成: L-丙氨酸0.2-0.4%、L-精氨酸0.2-0.5%、L-天冬氨酸0.7-1.0%、L-胱氨酸0.15-0.35%、L-谷氨酰胺1.6-2.0%、甘氨酸0.1-0.3%、L-组氨酸0.3-0.5%、L-异亮氨酸0.8-1.1%、L-亮氨酸1.4-1.6%、L-盐酸赖氨酸0.8-1.2%、L-甲硫氨酸0.2-0.4%、L-脯氨酸0.8-1.1%、L-丝氨酸0.3-0.6%、L-苏氨酸0.5-0.7%、L-色氨酸0.2-0.4%、L-酪氨酸0.8-1.2%和L-缬氨酸0.8-1.2%。
所述植物油脂肪粉由固体葡萄糖浆、预糊化淀粉、脂肪酸、乳化剂通过喷雾干燥而制成。
所述核苷酸由腺苷酸、尿苷酸、鸟苷酸、胞苷酸、肌苷酸组成,其质量比为2.9:3.5:1.0:5.1:2.0。
所述复合维生素由以下质量百分比的组分组成:维生素A0.00029-0.0009%、维生素C0.0525-0.357%、维生素D0.00000525-0.0000126%、维生素E0.00252-0.0252%、维生素K10.000021-0.0001365%、维生素B10.000294-0.001512%、维生素B20.000399-0.002499%、维生素B60.0001785-0.000945%、维生素B120.000000525-0.00000756%、烟酸0.00147-0.00756%、叶酸0.0000525-0.000252%、泛酸0.002-0.01%、生物素0.0000084-0.0000504%、肌醇0.021-0.1995%、胆碱0.0357-0.252%和牛磺酸0-0.063%。
所述复合矿物质由以下质量百分比的组分组成:钠0.105-0.294%、氯0.252-0.798%、钾0.294-0.903%、钙0.252-0.735%、磷0.126-0.504%、铁0.0021-0.00756%、锌0.00252-0.00756%、锰0.0000252-0.000504%、铜0.0001785-0.000609%、镁0.0252-0.0756%、硒0.00001-0.0000399%和碘0.0000525-0.000294%。
所述复合不饱和脂肪酸由DHA和ARA组成,DHA与ARA的重量比为1:1.8。
上述用于苯丙酮尿症患者的配方粉的制备方法如下:
(1)配料:将按预定比例称取原辅料,经复核准确后备用;
(2)投料:将已称量好的原辅料经投料站输送至三维混合机中;投料时注意将维生素、矿物质等质量比较小的原料放在大宗原料的中间投送,防止小料粘附在设备表面影响均匀性;
(3)混合搅拌:待所有的原辅料投送完毕,开启混合机搅拌,搅拌时间一般为8-12分钟(按混合的均匀程度确定混合时间);
(4)接料暂存:将混合好的物料输送至粉仓中暂存,检验部门取样进行过程产品检验;
(5)包装:采用自动包装机进行产品包装;
(6)检验:检验部门取样进行终产品检测。
实施例5
本发明的用于苯丙酮尿症患者的配方粉由如下质量百分比的组份制备而成:
植物油脂肪粉74.095%,复合氨基酸13.55%,低聚果糖(Fos)1.0 %,低聚半乳糖(Gos)6.45%,核苷酸0.058%,复合维生素0.13%和复合矿物质4.717%,所述配方粉中不包含苯丙氨酸。
所述复合氨基酸由以下质量百分比的组分组成: L-丙氨酸0.2-0.4%、L-精氨酸0.2-0.5%、L-天冬氨酸0.7-1.0%、L-胱氨酸0.15-0.35%、L-谷氨酰胺1.6-2.0%、甘氨酸0.1-0.3%、L-组氨酸0.3-0.5%、L-异亮氨酸0.8-1.1%、L-亮氨酸1.4-1.6%、L-盐酸赖氨酸0.8-1.2%、L-甲硫氨酸0.2-0.4%、L-脯氨酸0.8-1.1%、L-丝氨酸0.3-0.6%、L-苏氨酸0.5-0.7%、L-色氨酸0.2-0.4%、L-酪氨酸0.8-1.2%和L-缬氨酸0.8-1.2%。
所述植物油脂肪粉由固体葡萄糖浆、预糊化淀粉、脂肪酸、乳化剂通过喷雾干燥而制成。
所述核苷酸由腺苷酸、尿苷酸、鸟苷酸、胞苷酸、肌苷酸组成,其质量比为2.9:3.5:1.0:5.1:2.0。
所述复合维生素由以下质量百分比的组分组成:维生素A0.00029-0.0009%、维生素C0.0525-0.357%、维生素D0.00000525-0.0000126%、维生素E0.00252-0.0252%、维生素K10.000021-0.0001365%、维生素B10.000294-0.001512%、维生素B20.000399-0.002499%、维生素B60.0001785-0.000945%、维生素B120.000000525-0.00000756%、烟酸0.00147-0.00756%、叶酸0.0000525-0.000252%、泛酸0.002-0.01%、生物素0.0000084-0.0000504%、肌醇0.021-0.1995%、胆碱0.0357-0.252%和牛磺酸0-0.063%。
所述复合矿物质由以下质量百分比的组分组成:钠0.105-0.294%、氯0.252-0.798%、钾0.294-0.903%、钙0.252-0.735%、磷0.126-0.504%、铁0.0021-0.00756%、锌0.00252-0.00756%、锰0.0000252-0.000504%、铜0.0001785-0.000609%、镁0.0252-0.0756%、硒0.00001-0.0000399%和碘0.0000525-0.000294%。
上述用于苯丙酮尿症患者的配方粉的制备方法如下:
(1)配料:将按预定比例称取原辅料,经复核准确后备用;
(2)投料:将已称量好的原辅料经投料站输送至三维混合机中;投料时注意将维生素、矿物质等质量比较小的原料放在大宗原料的中间投送,防止小料粘附在设备表面影响均匀性;
(3)混合搅拌:待所有的原辅料投送完毕,开启混合机搅拌,搅拌时间一般为8-12分钟(按混合的均匀程度确定混合时间);
(4)接料暂存:将混合好的物料输送至粉仓中暂存,检验部门取样进行过程产品检验;
(5)包装:采用自动包装机进行产品包装;
(6)检验:检验部门取样进行终产品检测。
以上显示和描述了本发明的基本原理、主要特征和本发明的优点。本行业的技术人员应该了解,本发明不受上述实施例的限制,上述实施例和说明书中描述的只是本发明的原理,在不脱离本发明精神和范围的前提下本发明还会有各种变化和改进,这些变化和改进都落入要求保护的本发明的范围内。本发明要求的保护范围由所附的权利要求书及其等同物界定。
Claims (10)
1.一种用于苯丙酮尿症患者的配方粉,其特征在于,它由如下质量百分比的组份制备而成:
植物油脂肪粉60-90%,复合氨基酸8-20%,低聚果糖(Fos)0-6.45%,低聚半乳糖(Gos)0-6.45%,核苷酸0.012-0.058%,复合维生素0.06-0.41%和复合矿物质1.059-4.717%,所述配方粉中不包含苯丙氨酸。
2.根据权利要求1所述的配方粉,其特征在于,所述复合氨基酸由以下氨基酸组成:L-丙氨酸;L-精氨酸和/或L-盐酸精氨酸、L-天冬氨酸和/或L-天冬氨酸镁;L-胱氨酸、L-半胱氨酸、L-盐酸半胱氨酸中的一种或多种组合;L-谷氨酸、L-谷氨酸钾、L-谷氨酰胺中的一种或多种组合;甘氨酸;L-组氨酸和/或L-盐酸组氨酸;L-异亮氨酸、L-亮氨酸;L-盐酸赖氨酸和/或L-赖氨酸醋酸盐;L-甲硫氨酸和/或L-乙酰-甲硫氨酸;L-脯氨酸;L-丝氨酸;L-苏氨酸;L-色氨酸;L-酪氨酸;L-缬氨酸,并且L-酪氨酸占所述复合氨基酸重量的7-11%。
3.根据权利要求1所述的配方粉,其特征在于,所述复合氨基酸由以下质量百分比的组分组成: L-丙氨酸0.2-0.4%、L-精氨酸0.2-0.5%、L-天冬氨酸0.7-1.0%、L-胱氨酸0.15-0.35%、L-谷氨酰胺1.6-2.0%、甘氨酸0.1-0.3%、L-组氨酸0.3-0.5%、L-异亮氨酸0.8-1.1%、L-亮氨酸1.4-1.6%、L-盐酸赖氨酸0.8-1.2%、L-甲硫氨酸0.2-0.4%、L-脯氨酸0.8-1.1%、L-丝氨酸0.3-0.6%、L-苏氨酸0.5-0.7%、L-色氨酸0.2-0.4%、L-酪氨酸0.8-1.2%和L-缬氨酸0.8-1.2%。
4.根据权利要求1所述的配方粉,其特征在于,所述植物油脂肪粉由固体葡萄糖浆、预糊化淀粉、脂肪酸、乳化剂通过喷雾干燥而制成。
5.根据权利要求1所述的配方粉,其特征在于,所述核苷酸由腺苷酸、尿苷酸、鸟苷酸、胞苷酸、肌苷酸组成,其质量比为2.9:3.5:1.0:5.1:2.0。
6.根据权利要求1所述的配方粉,其特征在于,所述复合维生素由以下质量百分比的组分组成:维生素A0.00029-0.0009%、维生素C0.0525-0.357%、维生素D0.00000525-0.0000126%、维生素E0.00252-0.0252%、维生素K10.000021-0.0001365%、维生素B10.000294-0.001512%、维生素B20.000399-0.002499%、维生素B60.0001785-0.000945%、维生素B120.000000525-0.00000756%、烟酸0.00147-0.00756%、叶酸0.0000525-0.000252%、泛酸0.002-0.01%、生物素0.0000084-0.0000504%、肌醇0.021-0.1995%、胆碱0.0357-0.252%和牛磺酸0-0.063%。
7.根据权利要求1所述的配方粉,其特征在于,所述复合矿物质由以下质量百分比的组分组成:钠0.105-0.294%、氯0.252-0.798%、钾0.294-0.903%、钙0.252-0.735%、磷0.126-0.504%、铁0.0021-0.00756%、锌0.00252-0.00756%、锰0.0000252-0.000504%、铜0.0001785-0.000609%、镁0.0252-0.0756%、硒0.00001-0.0000399%和碘0.0000525-0.000294%。
8.根据权利要求1所述的配方粉,其特征在于,所述配方粉还包含质量百分比的复合不饱和脂肪酸0.12-0.16%,所述复合不饱和脂肪酸由DHA和ARA组成,DHA与ARA的重量比为1:1.8。
9.根据权利要求1所述的配方粉,其特征在于,所述配方粉还包含质量百分比的香精0.0-0.5%;所述香精为巧克力、香蕉、草莓、橙子、西柚及其他水果味中的一种。
10.一种用于苯丙酮尿症患者的配方粉的制备方法,其特征在于,它包括以下步骤:
(1)配料:将按预定比例称取原辅料,经复核准确后备用;
(2)投料:将已称量好的原辅料经投料站输送至混合机中;投料时注意将维生素、矿物质等质量比较小的原料放在大宗原料的中间投送,防止小料粘附在设备表面影响均匀性;
(3)混合搅拌:待所有的原辅料投送完毕,开启混合机搅拌,搅拌时间一般为8-12分钟(按混合的均匀程度确定混合时间);
(4)接料暂存:将混合好的物料输送至粉仓中暂存,检验部门取样进行过程产品检验;
(5)包装:采用自动包装机进行产品包装;
(6)检验:检验部门取样进行终产品检测。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810750645.5A CN110693031A (zh) | 2018-07-10 | 2018-07-10 | 一种用于苯丙酮尿症患者的配方粉及其制备方法 |
PCT/CN2019/084420 WO2020010896A1 (zh) | 2018-07-10 | 2019-04-26 | 一种用于苯丙酮尿症患者的配方粉及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810750645.5A CN110693031A (zh) | 2018-07-10 | 2018-07-10 | 一种用于苯丙酮尿症患者的配方粉及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110693031A true CN110693031A (zh) | 2020-01-17 |
Family
ID=69142227
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810750645.5A Pending CN110693031A (zh) | 2018-07-10 | 2018-07-10 | 一种用于苯丙酮尿症患者的配方粉及其制备方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN110693031A (zh) |
WO (1) | WO2020010896A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113785972A (zh) * | 2021-09-17 | 2021-12-14 | 江苏冬泽特医食品有限公司 | 用于罕见病苯丙酮尿症的营养粉、制备方法及用途 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103462003A (zh) * | 2013-08-13 | 2013-12-25 | 甘肃华羚生物技术研究中心 | 苯丙酮尿症病患者专用特膳食品 |
CN104012659A (zh) * | 2014-06-26 | 2014-09-03 | 中恩(天津)营养科技有限公司 | 一种用于苯丙酮尿症儿童的配方粉及其制备方法 |
CN106686990A (zh) * | 2014-07-01 | 2017-05-17 | N·V·努特里奇亚 | 味道改善的基于氨基酸的膳食 |
CN107212093A (zh) * | 2017-06-30 | 2017-09-29 | 杭州千岛湖康诺邦健康产品有限公司 | 一种苯丙氨酸障碍代谢配方奶粉 |
CN107751998A (zh) * | 2017-09-29 | 2018-03-06 | 赤峰禾士营养食品科技有限公司 | 一种用于苯丙酮尿症患者的食用配方粉 |
-
2018
- 2018-07-10 CN CN201810750645.5A patent/CN110693031A/zh active Pending
-
2019
- 2019-04-26 WO PCT/CN2019/084420 patent/WO2020010896A1/zh active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103462003A (zh) * | 2013-08-13 | 2013-12-25 | 甘肃华羚生物技术研究中心 | 苯丙酮尿症病患者专用特膳食品 |
CN104012659A (zh) * | 2014-06-26 | 2014-09-03 | 中恩(天津)营养科技有限公司 | 一种用于苯丙酮尿症儿童的配方粉及其制备方法 |
CN106686990A (zh) * | 2014-07-01 | 2017-05-17 | N·V·努特里奇亚 | 味道改善的基于氨基酸的膳食 |
CN107212093A (zh) * | 2017-06-30 | 2017-09-29 | 杭州千岛湖康诺邦健康产品有限公司 | 一种苯丙氨酸障碍代谢配方奶粉 |
CN107751998A (zh) * | 2017-09-29 | 2018-03-06 | 赤峰禾士营养食品科技有限公司 | 一种用于苯丙酮尿症患者的食用配方粉 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113785972A (zh) * | 2021-09-17 | 2021-12-14 | 江苏冬泽特医食品有限公司 | 用于罕见病苯丙酮尿症的营养粉、制备方法及用途 |
CN113785972B (zh) * | 2021-09-17 | 2023-10-24 | 江苏冬泽特医食品有限公司 | 用于罕见病苯丙酮尿症的营养粉、制备方法及用途 |
Also Published As
Publication number | Publication date |
---|---|
WO2020010896A1 (zh) | 2020-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
He et al. | Amino acid nutrition and metabolism in chickens | |
Rezaei et al. | Biochemical and physiological bases for utilization of dietary amino acids by young pigs | |
US9943097B2 (en) | Nutritional composition | |
EP2026791B2 (en) | Maternal supplement | |
AU2009306497B2 (en) | Nutritional composition with anti-regurgitation properties | |
CN107467667B (zh) | 一种含有两种不饱和脂肪酸和唾液酸的复方制剂 | |
CN105558046A (zh) | 一种用于肝病患者的特殊医学用途配方食品及其制备方法 | |
CN102731331A (zh) | 一种l-天门冬氨酸钙及其制备方法 | |
Nayman et al. | Observations on the composition of milk-substitute products for treatment of inborn errors of amino acid metabolism. Comparisons with human milk. A proposal to rationalize nutrient content of treatment products2 | |
Kashyap | Enteral intake for very low birth weight infants: what should the composition be? | |
Rérat | Nutritional supply of proteins and absorption of their hydrolysis products: consequences on metabolism | |
CN110693031A (zh) | 一种用于苯丙酮尿症患者的配方粉及其制备方法 | |
Jitomir et al. | Leucine for retention of lean mass on a hypocaloric diet | |
JPH08175987A (ja) | 経口経腸栄養組成物 | |
CN103053807B (zh) | 一种水溶性复合维生素制剂及其制备方法 | |
Chwals | Regulation of the cellular and physiological effects of glutamine | |
TW200405007A (en) | Analytical method for the determination of infant formula protein digestibility in vitro | |
CN101402583B (zh) | 左旋肉碱磷酸二氢钙及其制备方法与用途 | |
CN111134323A (zh) | 一种适合脑力劳动者的液态全营养补充剂及其制备方法 | |
Bodamer et al. | Overview of phenylketonuria | |
US20230346731A1 (en) | Amino acid compositions and functional food affecting tumor growth and uses thereof | |
CN107467673B (zh) | 一种含有三种不饱和脂肪酸和锌的复方制剂 | |
Gunarathne et al. | L-lysine dietary supplementation for childhood and adolescent growth: Promises and precautions | |
CN110973634A (zh) | 改善发育迟缓的营养组合物及其制备方法 | |
US20210228683A1 (en) | Whey protein concentrate in association with antitumour treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200117 |
|
WD01 | Invention patent application deemed withdrawn after publication |